EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunization with recombinant Streptococcus pneumoniae PgdA protects mice against lung invasion

Jiangming Xiao, Bichen Liu, Yibing Yin, Xuemei Zhang

Experimental Biology and Medicine · 2024

DOI: 10.3389/ebm.2024.10119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Biology and Medicine, 2024. Verfasst von Jiangming Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chongqing General Hospital, Chongqing University, Chongqing, China. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Pneumococcal Vaccines, Pneumococcal Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current pneumococcal vaccines, including the pneumococcal polysaccharide (PPV23) and conjugate (PCV13) vaccines, offer protection against specific serotypes but pose risks of serotype replacement that can alter the composition of the nasopharyngeal microbiota. To address this challenge, a novel strategy has been proposed to provide effective protection without disrupting the colonization of other bacterial populations. In our study, we found that subcutaneous immunization with recombinant peptidoglycan N-acetylglucosamine deacetylase A (rPgdA) elicited robust humoral and cellular immune responses, significantly reducing the invasion of Streptococcus pneumoniae in the lungs without affecting nasopharyngeal carriage. Furthermore, rPgdA antisera were shown to diminish bacterial invasion of lung epithelial cells in vitro . Notably, sera from patients with invasive pneumococcal infections exhibited higher levels of antibodies against the PgdA protein compared to sera from healthy adults, suggesting that a natural immune response to this protein occurs during infection. These results suggest a promising new target for the development of pneumococcal vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaePneumococcal VaccinesPneumococcal InfectionsAnimalsMiceFemaleHumansLungAntibodies, BacterialMice, Inbred BALB CRecombinant ProteinsImmunizationBacterial Proteins

Stichwörter der Autor:innen

PgdAStreptococcus pneumoniaecolonizationnovel strategyvaccine candidate

Substanzen

Pneumococcal VaccinesAntibodies, BacterialRecombinant ProteinsBacterial Proteins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Chongqing General Hospital, Chongqing University, Chongqing, China.
  • Department of Laboratory Medicine, Key Laboratory of Diagnostic Medicine (Ministry of Education), Chongqing Medical University, Chongqing, China.

Zitieren

APA

Xiao, J., Liu, B., Yin, Y., & Zhang, X. (2024). Immunization with recombinant Streptococcus pneumoniae PgdA protects mice against lung invasion. Experimental Biology and Medicine. https://doi.org/10.3389/ebm.2024.10119

Vancouver

Xiao J, Liu B, Yin Y, Zhang X. Immunization with recombinant Streptococcus pneumoniae PgdA protects mice against lung invasion. Experimental Biology and Medicine. 2024. doi:10.3389/ebm.2024.10119

BibTeX
@article{Xiao2024,
  author = {Xiao, Jiangming and Liu, Bichen and Yin, Yibing and Zhang, Xuemei},
  title = {Immunization with recombinant Streptococcus pneumoniae PgdA protects mice against lung invasion},
  journal = {Experimental Biology and Medicine},
  year = {2024},
  doi = {10.3389/ebm.2024.10119}
}
Kostenlos starten →